There's No Going Back
Discover how changes accelerated by the pandemic in telehealth and remote patient monitoring are transforming care delivery and impacting drug development.
The Power of Next Gen Cell Therapies: Pipedreams or Reality?
Cellular therapies have made a major impact in hematologic malignancy. This session will examine how we can extend and expand the use of cellular based immunotherapies for a greater diversity of cancers and in a greater diversity of clinical settings. Innovation in engineering cutting edge products will also be discussed.
Paying for Innovation
Join us for a lively conversation about the kinds of drug pricing reforms our industry can support, that expand incentives for innovation without causing the financial burdens for patients and families we see too much of today.
New Treatments and Potential Cures in Alzheimer’s Disease and Neurodegeneration: The Future is Here!
This panel will discuss the rapidly evolving scientific landscape in neurodegeneration, historically a very challenging space. Are there valid reasons to be optimistic in the near-to-mid-term? The panel will cover a number of hot topics, including the wide array of approaches under examination in Alzheimer’s; the utility of biomarkers in CNS; and the impact of genetics on CNS drug development, patient enrichment strategies and the discovery of new targets.